Anne Mei Chang
Ann Mei Chang is the former chief innovation officer and executive director of the U.S. Global Development Lab at USAID. The lab is the newest bureau at USAID and leverages 21st century advances in technology and innovation to accelerate the impact and scale of global development.
Previously, Ann Mei was the chief innovation officer at Mercy Corps and served as the senior advisor for women and technology in the secretary’s Office of Global Women’s Issues at the U.S. Department of State. Prior to her pivot to the public sector, Ann Mei spent more than 20 years at leading Silicon Valley companies, including Google, Apple, Intuit, and several startups. Most recently, she was as a senior engineering director at Google, where she led worldwide engineering for mobile applications and services.
“Over the next decade, I hope to see dramatic acceleration in innovation, delivery, and massively scaling holistic solutions to global health challenges. PATH is leading the way to that future.”
Molly Joel Coye, MD, MP
Dr. Molly Joel Coye is executive-in-residence at AVIA, a network of large health systems working to transform health care delivery through digital innovation. From 2010 to 2015, Molly served as chief innovation officer for UCLA Health and head of the Institute for Innovation at UCLA, where she identified new strategies, technologies, products, and services to support large-scale health care transformation.
Molly also founded and served as CEO of the Health Technology Center, the premier forecasting organization for emerging technologies in health care. She has served as commissioner of health for the State of New Jersey, director of the California Department of Health Services, and head of the Division of Public Health Practice at the Johns Hopkins University School of Hygiene. An elected member of the National Academy of Medicine, Molly serves on the board of directors of Aetna, Inc., and on advisory boards of several other organizations. She is a former member of PATH’s board of directors.
Dennis Henner, PhD
Dr. Dennis Henner is chief scientific advisor at Clarus, a global investment firm dedicated to life sciences, which he joined as managing director at its inception in 2005. He has worked in health care and health care investment for more than 30 years, including as a general partner at the health care venture capital firm MPM Capital. From 1981 to 2001, Dennis was an executive at Genentech, where he held various positions, including senior vice president of research, and was a member of the company’s executive committee.
Dennis earned his PhD from the Department of Microbiology at the University of Virginia and did postgraduate training at the Scripps Clinic and Research Foundation. He serves on the boards of directors at Cleave Biosciences, Forty Seven Sciences, and Imago BioSciences. He is also a trustee of Reed College.
“The first reason I chose to get involved with PATH was the outsized impact it has on people's lives, which by extension leverages the impact of any small contribution I might make. The second reason is the people at PATH—an amazing group of interesting, pragmatic people dedicated to improving global health.”
Chris Jaeger, MD, MBA
Dr. Chris Jaeger is vice president of accountable care innovation and clinical transformation at Blue Shield of California (BSC), where he is responsible for leading operational and care delivery enhancements with existing BSC accountable care partners and creating and implementing new value-based care models. Chris also leads collaborative efforts to identify, assess, and implement novel information technology and digital health solutions to enhance health care quality, affordability, and experience.
Prior to joining BSC, Chris was chief medical information officer for Sutter Health, where he was responsible for identifying, implementing, and maximizing the use and value generation of health information systems and emerging technologies across the Northern California integrated delivery network.
Chris earned his medical degree and completed an internal medicine residency at Johns Hopkins University, and he earned an MBA with a certificate in health care management from the UC-Berkeley Haas School of Business.
“As a clinician, I have seen the devastating impact illness can have on peoples’ lives. Yet, the prevalence of illness and its impact is not uniform across the globe. I am incredibly honored to contribute to PATH’s ‘unshakeable commitment to health equity and. . .bold belief in the power of innovation to improve health.’”
Dr. Anurag Mairal is a Consulting Associate Professor of Medicine and the Director, Global Exchange Program at Stanford Byers Center for Biodesign, Stanford University. In these roles, he leads initiatives focused on applying the biodesign process to resource-constrained settings globally. Further, he facilitates opportunities for students, faculty and fellows at Stanford to work on global healthcare needs.
He is part of the founding faculty team for BIOE 371, Global Biodesign: Medical Technology in an International Context, a graduate-level course offered to engineering, business, and medical students at Stanford University. He also has additional appointments as an Adjunct Professor at Stanford Graduate School of Business and Faculty Fellow at the Center for Innovation in Global Health. As a Co-Director of the India Biodesign Phase II initiative, he leads the Forum, a platform for supporting India's medtech entrepreneurs. As the Chair of a BME IDEA APAC, a new initiative to bring together medtech innovation programs in Asia Pacific region, he is focused on building a sustainable organization that supports the needs of innovation stakeholders in the region.
Earlier, he served as Associate Director for the Stanford-India Biodesign and Singapore-Stanford Biodesign programs. Concurrently, he is a co-founder and Executive Vice President of Orbees Medical, a SF Bay Area-based strategy consulting firm serving global healthcare industry, with a focus on medtech, pharmaceutical, and digital health industry.
Tim Ritchie, JD, MPA
Tim Ritchie is president and CEO of The Tech Museum of Innovation in San José, California. Tim joined The Tech in 2011 with a mandate to breathe life into its mission: inspiring the innovator in everyone. Since then, the institution has transformed its exhibits and programs to make them more relevant to schools, families, and the community. Tim came to The Tech from McWane Science Center in Birmingham, Alabama, where he was president and CEO. A varied career led him to the science center world.
After earning his bachelor’s degree from Davidson College and his JD from Duke Law School, Tim worked as a clerk for the chief justice of the North Carolina Supreme Court, represented defendants on North Carolina’s death row, practiced law in Birmingham, and was president of Louisville Diversified Services, a Kentucky nonprofit supporting adults with developmental disabilities. He also holds a master’s degree in public administration from Harvard University.
“PATH is worth my time because it does the hard work of making a difference at scale. With infinite patience and creativity, PATH connects medical innovation with civic innovation in the effort to help billions overcome disease and increase opportunity.”
Faith Sedlin is CMO of the international non profit Kiva. For the past 20 years, Faith has played leadership roles in consumer technology companies ranging from fledging concepts to public companies. Most recently, as CMO of Redbubble, she scaled marketing leading up to the company’s successful IPO. Previously, she was part of the early team that defined and launched Siri. As an Oodle co-founder, she grew the company from its infancy to 10 million users. She was also the first product manager of eBay.
In the nonprofit sector, Faith was formerly an advisor to Blue Planet Network. She graduated with a bachelor’s degree from Wellesley College and an M.B.A. from Harvard University.
Chuck Slaughter, MPPM
After founding TravelSmith and growing it into a leading travel gear company, Chuck Slaughter teamed up with private equity firm Golden Gate Capital and participated in the acquisition and turnaround of several major apparel brands. Chuck is also founder and president of Living Goods, a franchise system that recruits and supports networks of village health workers in Africa and Asia who go door-to-door teaching better health practices and selling basic health products.
Chuck is a senior advisor at TPG Capital and serves on the boards of the Yale University School of Management, Tidepool, and the Goldsmith Foundation. He has received awards from Skoll Foundation, E&Y, and the World Economic Forum. He earned a BA in architecture and a master’s in public and private management from the Yale University School of Management.
“Virtually every other sector—from books to retail to taxis—has been positively reinvented by mobile technology. Now it’s time for technology to reinvent global health on a game-changing scale by transforming ordinary villagers into lifesaving community health workers.”
Frank Williams, MBA
Frank Williams is cofounder and CEO of Evolent Health, which helps physicians and health systems achieve superior performance through value-based care transformation in order to dramatically improve the health of the populations that it serves. The company partners with leading health systems in more than 30 markets, manages more than 2.5 million lives under value-based arrangements, and employs over 2,500 professionals nationwide.
Prior to Evolent, Frank was chairman and CEO of The Advisory Board Company, a global research and technology firm that serves more than 5,000 organizations across the health care and higher education sectors. In addition to serving on the Evolent Health board of directors, he serves on the boards of the Business Talent Group and Peer Health Exchange and is active philanthropically in initiatives related to public health and education. A native Californian, Frank earned a BA in political economy from UC Berkeley and an MBA from Harvard Business School.
“It’s incredibly gratifying to be around mission-driven, passionate experts in their field who have devoted their lives to making a difference in health equity worldwide.”